About Organon & Co. 
Organon & Co.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 128 Schemes (56.13%)
Foreign Institutions
Held by 252 Foreign Institutions (16.4%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
1,594 Million
(Quarterly Results - Jun 2025)
Net Profit:
145 Million
Pharmaceuticals & Biotechnology
USD 2,722 Million (Small Cap)
3.00
NA
0.38%
11.32
111.78%
3.71






